IL Receptor
Interleukin receptors (IL receptors) are a group of receptors that bind to interleukins, a family of cytokines that play essential roles in immune system regulation, inflammation, and hematopoiesis. Dysregulation of interleukin signaling is associated with various inflammatory and autoimmune diseases, making IL receptors critical targets for therapeutic intervention. IL receptor antagonists are being explored for the treatment of conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. At CymitQuimica, we offer a range of high-quality IL receptor modulators to support your research in cytokine signaling, immunology, and inflammatory disease therapy.
Found 111 products of "IL Receptor"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Olokizumab
CAS:Revdofilimab (ABBV-368) is a human IgG monoclonal antibody targeting OX 40 with potential anticancer activity.Purity:99% (SDS-PAGE); 98.3% (SEC-HPLC) - 99% (SDS-PAGE); 98.3% (SEC-HPLC)Color and Shape:LiquidMolecular weight:145.39 kDaElsilimomab
CAS:Elsilimomab (B-E8) is a monoclonal antibody targeting IL-6, inhibiting the induction of bone marrow stromal cell senescence by dnmt3a mutation clones.Purity:>95%Color and Shape:LiquidMolecular weight:145.96 kDaImsidolimab
CAS:Imsidolimab (ANB 019) is a humanized anti-IL-36R monoclonal antibody that inhibits IL-36 signaling and can be used to study systemic pustular psoriasis.Purity:99.1% (SDS-PAGE); 96.7% (SEC-HPLC) - 99.1% (SDS-PAGE); 96.7% (SEC-HPLC)Color and Shape:LiquidMolecular weight:146.71 kDaMirikizumab
CAS:Mirikizumab (LY3074828) is a humanized antibody targeting the p19 subunit of interleukin-23 (IL-23).Purity:98.41% (SEC-HPLC) - 98.41% (SEC-HPLC)Color and Shape:LiquidMolecular weight:144.26 kDaPerakizumab
CAS:Perakizumab (RG4934) is a humanized monoclonal antibody targeting IL-17A, used in the study of psoriatic arthritis and other autoimmune diseases.Purity:95.28% (SEC-HPLC) - 99.66% (SEC-HPLC)Color and Shape:LiquidMolecular weight:145.8 kDaDupilumab
CAS:Dupilumab (REGN-668) is a systemic immunomodulator for AD.Purity:95.00% - >99.2%Color and Shape:LiquidMolecular weight:149.8 kDaSarilumab
CAS:Sarilumab: Potent IL-6 blocker, human antibody, reduces inflammation, treats rheumatoid arthritis.Purity:97.4%Color and Shape:LiquidMolecular weight:144.12 kDaBriakinumab
CAS:Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the research of psoriasis multiple sclerosis.Purity:>95%Color and Shape:LiquidMolecular weight:143.86 kDaIL-15-IN-1
CAS:IL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).Formula:C30H36N6O4SPurity:99.16%Color and Shape:SolidMolecular weight:576.71Ref: TM-T11634
1mg84.00€5mg161.00€1mL*10mM (DMSO)198.00€10mg245.00€25mg406.00€50mg572.00€100mg772.00€200mg1,035.00€2-Benzothiazolamine
CAS:2-ABT: nitrogen-rich heterocycle used in drug synthesis, inhibits P450, with anti-inflammatory, anticonvulsant, anticancer properties.Formula:C7H6N2SPurity:99.09% - 99.3%Color and Shape:Plates From Water Physical Description Odorless Gray To White Powder (Ntp 1992)Molecular weight:150.2Siltuximab
CAS:Siltuximab（CNTO-328） is a monoclonal antibody with anti-tumor activity targeting IL-6 for the study of giant lymph node hyperplasia (MCD) and COVID-19.Purity:100% (SEC-HPLC) - > 95%Color and Shape:LiquidMolecular weight:144.98 kDaEnokizumab
CAS:Enokizumab (MEDI-528) is a monoclonal antibody against interleukin IL-9. Enokizumab can be used to study asthma.Purity:SDS-PAGE:95% SEC-HPLC:99.23%Color and Shape:LiquidMolecular weight:145.98 kDaRisankizumab
CAS:Risankizumab (BI 655066) is a monoclonal antibody for psoriasis, targeting IL-23, with high affinity (Kd <10 pM) and an IC50 of 2 pM.Purity:SDS-PAGE:95.3%;SEC-HPLC:98.3%Color and Shape:LiquidMolecular weight:145.85 kDaOrdesekimab
CAS:Ordesekimab (AMG 714) is a human anti-IL-15 IgG1 κ monoclonal antibody for studying NRCD.Purity:> 95%Color and Shape:LiquidMolecular weight:145.12 kDaTildrakizumab
CAS:Tildrakizumab (SCH 900222) is a humanized antibody against IL-23, with a 136 pM Kd, used for psoriasis research.Purity:> 95%Color and Shape:LiquidMolecular weight:144.44 kDaBrodalumab
CAS:Brodalumab (AMG 827), a human IgG2 monoclonal antibody, inhibits IL-17R, treating psoriasis.Purity:98.3%Color and Shape:LiquidMolecular weight:144.06 kDaOlamkicept
CAS:Olamkicept (FE-301) is a soluble gp130-Fc-fusion protein that inhibits interleukin 6 (IL-6) trans signaling.Purity:98.2% (SDS-PAGE); 98.8% (SEC-HPLC) - 99.3% (SDS-PAGE); 97.6% (SEC-HPLC)Color and Shape:LiquidMolecular weight:93.14 kDaSpesolimab
CAS:Spesolimab (BI 655130) is an antibody targeting IL-36 receptor, key in immunity, for systemic pustular psoriasis and dermatitis studies.Purity:> 95%Color and Shape:LiquidMolecular weight:150 kDaNidanilimab
CAS:Nidanilimab (CAN04) is an IL1RAP antibody with 1.10 pM affinity and antitumor effects on NSCLC and PDAC.
Purity:> 95%Color and Shape:SoildMolecular weight:150 kDaVobarilizumab
CAS:Vobarilizumab (ALX-0061) is a humanized specific antibody targeting IL-6R and ALB, used in research on autoimmune diseases like rheumatoid arthritis.Purity:>95%Color and Shape:LiquidMolecular weight:78.2 kDa
